In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Zakhiriddin KhojakulovNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.ORCID 0000-0002-7771-8956 Robin J PalvadeauNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.
Müge Kovancılar-KoçNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.ORCID 0009-0006-7125-1159 Irmak AtayNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.ORCID 0009-0007-3284-7790 Irmak ŞahbazNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.ORCID 0000-0001-8816-9158 Şeyma TekgülNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.ORCID 0000-0001-5223-5627 Ayça ŞahinNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.ORCID 0000-0002-0948-6495 Esmer Zeynep Duru BadakalNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.
Tuğçe Gül-DemirkaleNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.ORCID 0000-0002-1818-9839 Vildan ÇiftçiNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.ORCID 0000-0002-4441-6062 Elif BayraktarNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.
Ceren TuncaNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.
Natalia SmolinaNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.
Fulya AkçimenLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
Ayşe Nazlı BaşakNeurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine (KUTTAM), School of Medicine, Koç University, 34010 Istanbul, Turkey.ORCID 0000-0001-6977-2517 Funding
Koç University Koc universitySuna and İnan Kıraç Foundation Suna and İnan Kıraç Foundation
6 · The paper itselfAbstract
Short tandem repeat (STR) expansions are a major cause of neurodegenerative disorders; however, their genetic and clinical heterogeneity complicates diagnosis. STR detection remains limited in routine short-read next-generation sequencing (NGS) workflows. We evaluated the diagnostic yield and clinical utility of computational STR genotyping in a large Turkish neurodegenerative disease cohort. ExpansionHunter was applied to NGS data from 3150 patients and 146 controls, targeting 15 disease-associated STR loci. To improve genotyping of poorly captured exonic regions in exome data, the default locus coverage threshold was reduced from 10× to 3×. Candidate expansions were visually inspected using REViewer and validated by conventional molecular methods. Computational analysis detected 28 pathogenic and 160 intermediate expansions. Of these, 23 were confirmed as pathogenic, and eight initially classified as intermediate were reclassified as pathogenic after conventional validation, resulting in 31 pathogenic cases across 28 families:
Indexed as
DNA Repeat ExpansionGenotyping TechniquesMicrosatellite RepeatsNeurodegenerative DiseasesCohort StudiesComputational BiologyFemaleGenotypeHigh-Throughput Nucleotide SequencingHumansMaleTurkeycomputational genotypingExpansionHunterneurodegenerative diseasesNGSshort tandem repeatsSTR
Identifiers
PMID42196324
PMCPMC13207311
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390